This study assessed relationships among individual differences in trait motivational reactivity, executive functioning, and neurovisceral regulation of emotion and attention indexed via resting heart rate variability (rHRV). We derived predictions regarding these relationships according to neurovisceral neural network theory. Because lower rHRV has been suggested as an endophenotype of less adaptive behaviour, low rHRV individuals were predicted to have high aversive and low appetitive trait motivational reactivity, while high rHRV individuals were predicted to have high reactivity in both appetitive and aversive motivational systems. These predictions were supported. Motivational reactivity also was related to executive functioning deficits, although the pattern of results was not in the predicted direction. Results suggest that trait motivational reactivity scores are related to visceral responses proposed in the neurovisceral integration circuit as well as in the modulation of these responses by higher-order cognitive control systems related to executive function.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/02699931.2014.893864 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Iron oxide nanoparticles: a versatile nanoplatform for the treatment and diagnosis of ovarian cancer.
Ther Deliv
December 2024
Department of Pharmaceutics, University Institute of Pharma Sciences, Chandigarh University, Mohali, India.
Ovarian cancer remains one of the main causes of human mortality, accounting for millions of deaths every year. Despite of several clinical options such as chemotherapy, photodynamic therapy (PDT), hormonal treatment, radiation therapy, and surgery to manage this disease, the mortality rate is still very high. This alarming statistic highlights the urgent need for innovative approaches to improve both diagnosis and treatment.
View Article and Find Full Text PDFRepurposing pinaverium bromide against Staphylococcus and its biofilms with new mechanisms.
AMB Express
December 2024
Department of Laboratory Medicine, The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha), Central South University, No. 311, Yingpan Road, Changsha, 410005, Hunan, China.
Antibiotic resistance by methicillin-resistant Staphylococcus aureus (MRSA) is an urgent threat to human health. The biofilm and persister cells formation ability of MRSA and Staphylococcus epidermidis often companied with extremely high antimicrobial resistance. Pinaverium bromide (PVB) is an antispasmodic compound mainly used for irritable bowel syndrome.
View Article and Find Full Text PDFChanging mindsets about methotrexate in the rheumatology clinic to reduce side effects and improve adherence: a randomized controlled trial.
Ann Behav Med
December 2024
Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1142, New Zealand.
Background: Patients' negative expectations about medication can exacerbate side effect burden leading to low adherence and persistence. A novel intervention involves targeting mindsets about non-severe symptoms; reframing them as encouraging signs of medication working.
Purpose: This study aimed to assess whether a brief symptom-mindset intervention can improve symptom experience and adherence in patients starting methotrexate to treat an inflammatory rheumatic disease.
A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder.
JCI Insight
December 2024
Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural Clinical and Biological Research, NIH, Baltimore and Bethesda, Maryland, USA.
BACKGROUNDStudies have demonstrated the role of ghrelin in alcohol-related behaviors and consumption. Blockade of the growth hormone secretagogue receptor (GHSR), which is the ghrelin receptor, has been shown to decrease alcohol drinking and reward-related behaviors across several animal models. We previously conducted a human study testing a GHSR inverse agonist/competitive antagonist, PF-5190457, in individuals who are heavy drinkers and showed its safety when coadministered with alcohol.
View Article and Find Full Text PDFCraving changes in first 14 days of addiction treatment: an outcome predictor of 5 years substance use status?
Transl Psychiatry
December 2024
Univ. Bordeaux, CNRS, SANPSY, UMR 6033, F-33076, Bordeaux, France.
Addiction is considered a chronic disorder that requires long-term treatment. Early identification of predictors of outcome may enable better and early adjustment of treatment. Daily fluctuations of craving have been shown to predict substance use within hours, making it a major target for treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!